State Street’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

State Street’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-457,674	Closed	-$5.62M	–	4885
2022 Q4	$5.62M	Buy	457,674 +49,798	+12%	+$1.19M	﹤0.01%	2991
2022 Q3	$13.4M	Buy	407,876 +184,496	+83%	+$5.21M	﹤0.01%	2526
2022 Q2	$4.21M	Buy	223,380 +99,371	+80%	+$1.9M	﹤0.01%	3180
2022 Q1	$2.17M	Buy	+124,009	New	+$2.54M	﹤0.01%	3534

State Street's CINC Position: Q1 2023 in Review

State Street sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 457,674 shares — an estimated $5.62M sold.

State Street first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $13.4M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

State Street reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
State Street sold 457,674 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $5.62M.
State Street first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
State Street's CinCor Pharma, Inc. Common Stock position peaked at $13.4M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.